Publications - PulmoTension

Retrouvez les publications scientifiques majeures relatives à l’hypertension pulmonaire auxquelles les membres des centres de référence et de compétence PulmoTension ont contribué.

Rechercher une publication :

10/2026
Multimodal investigation of the association between bevacizumab and pulmonary arterial hypertension (nouvel onglet)

Valentin S, Hlavaty A, Brossat C, Chaumais MC, Artaud-Macari É, Mauran P, Maurac A, Savale L, Sitbon O, Humbert M, Chaouat A, Khouri C, Montani D

ERJ Open Res. 2026 Oct 12;12(5):00209-2026. doi: 10.1183/23120541.00209-2026. PMID: 42865918; PMCID: PMC13656190
10/2026
Haemodynamic responses to sotatercept and parenteral prostacyclins in pulmonary arterial hypertension patients (nouvel onglet)

Genecand L, Boucly A, Beurnier A, Jaïs X, Degano B, Prevot G, Gerges C, Lamblin N, Bauer F, Savale L, Sitbon O, Chemla D, Humbert M, Montani D

J Heart Lung Transplant. 2026 Oct;45(10):1685-1696. doi: 10.1016/j.healun.2026.05.028. Epub 2026 Jun 1. PMID: 42229625
10/2026
Impact of Pulmonary Arterial Hypertension Therapies on Gas Exchange in Portopulmonary Hypertension (nouvel onglet)

Lacoste-Palasset T, Baron A, Ebstein N, Beurnier A, Grech AK, Robert F, Tu L, Jevnikar M, Jaïs X, Boucly A, Valentin S, Magro P, Horeau-Langlard D, Aguado B, Guignabert C, Bauer F, Montani D, Humbert M, Sitbon O, Savale L

Chest. 2026 Oct;170(4):1205-1217. doi: 10.1016/j.chest.2026.04.027. Epub 2026 Apr 30. PMID: 42066896
09/2026
Pulmonary vascular reactivity in severe pulmonary hypertension associated with COPD (nouvel onglet)

Jutant EM, Delarche B, Croquette M, Beurnier A, Diaz A, Bironneau V, Caron F, Riou M, Boucly A, Jaïs X, Savale L, Sitbon O, Bertoletti L, Humbert M, Montani D

ERJ Open Res. 2026 Sep 28;12(5):01606-2025. doi: 10.1183/23120541.01606-2025. PMID: 42807362; PMCID: PMC13617601
09/2026
Effective arterial elastance relates more closely to pulsatile than resistive indices during routine haemodynamic assessment of inoperable chronic thromboembolic pulmonary hypertension (nouvel onglet)

Chemla D, Jaïs X, Jevnikar M, Brenot P, Gerges C, Beurnier A, Boucly A, Savale L, Sitbon O, Humbert M, Hervé P, Montani D

ERJ Open Res. 2026 Sep 21;12(5):00397-2026. doi: 10.1183/23120541.00397-2026. PMID: 42769750; PMCID: PMC13591296
09/2026
Beyond Heritable PAH: Pulmonary Hypertension in Genetic Syndromes (nouvel onglet)

Grynblat J, Coulet F, Lacoste-Palasset T, Jais X, Austin E, Ivy D, Ghigna MR, Beauvais A, Jutant EM, Boucly A, Meot M, Malekzadeh-Milani SG, Levy M, Antigny F, Ruffenach G, Sitbon O, Savale L, Humbert M, Bonnet D, Montani D

Eur Respir J. 2026 Sep 10:2600808. doi: 10.1183/13993003.00808-2026. Epub ahead of print. PMID: 42722401
09/2026
European Respiratory Society clinical practice guidelines update for the treatment of pulmonary arterial hypertension (nouvel onglet)

Kovacs G, Zeder K, Humbert M, Condliffe R, Toews I, Boucly A, Aldred M, Badagliacca R, Chung W, De Man F, Dorfmüller P, Ferrari P, Giannakoulas G, Harari S, Kotsimbos T, Tsang NNY, Quarck R, Rodrigues A, Rosenkranz S, Sitbon O, Vonk Noordegraaf A, Zhao L, Hoeper M, Delcroix M

Eur Respir J. 2026 Sep 7:2601178. doi: 10.1183/13993003.01178-2026. Epub ahead of print. PMID: 42705705.
08/2026
Ralinepag for the treatment of pulmonary arterial hypertension (ADVANCE OUTCOMES): a randomised, double-blind, placebo-controlled phase 3 study (nouvel onglet)

McLaughlin VV, Solum D, Lachant D, Ataya A, Barberà JA, Meyer GB, Chang SA, Channick R, Church C, Feenstra J, Gaine S, Giannakoulas G, Jerjes-Sanchez C, Khanna D, Kim NH, Oudiz R, Preston IR, Sood N, Torres F, Vachiery JL, Pulido T, Cella D, Deng C, Escudero M, Lacasse V, Peterson L, Benza R, Humbert M; ADVANCE OUTCOMES Investigators

Lancet. 2026 Aug 8;408(10554):521-531. doi: 10.1016/S0140-6736(26)01011-1. Epub 2026 Jul 28. PMID: 42520828
08/2026
Prognostic factors in interstitial lung disease-associated pulmonary hypertension: data from the HYPID cohort and the French Pulmonary Hypertension Registry (nouvel onglet)

Diesler R, Turquier S, Reynaud-Gaubert M, Lestelle F, Lacoste-Palasset T, Valentin V, Quétant S, Chaouat A, Boissin C, Noël-Savina É, Tromeur C, Justet A, Maurac A, Artaud-Macari É, Nunes H, Bertoletti L, Magro P, Horeau-Langlard D, Seronde MF, Favrolt N, Trésorier R, Lamia B, Chabanne C, Riou M, Renard S, Sanchez O, Gagnadoux F, Nieves A, Ahmad K, Traclet J, Sitbon O, Lamblin N, Degano B, Valentin S, Bourdin A, Humbert M, Boucly A, Subtil F, Montani D, Cottin V; PulmoTension and OrphaLung networks

Eur Respir J. 2026 Aug 6;68(2):2502233. doi: 10.1183/13993003.02233-2025. PMID: 41887671
08/2026
Circulating biomarker results from a phase 2 study of seralutinib in pulmonary arterial hypertension (nouvel onglet)

Osterhout R, Boucly A, Benza RL, Channick RN, Chin KM, Frantz RP, Hemnes AR, Howard LS, McLaughlin VV, Sitbon O, Vachiéry JL, Zamanian RT, Aranda R, Cravets M, Ding Z, Duong-Verlé T, Mottola D, Roscigno RF, Sitapara R, Zisman LS, Bruey JM, Ghofrani HA

Am J Respir Crit Care Med. 2026 Aug 1;212(8):1832-1837. doi: 10.1093/ajrccm/aamag175. PMID: 42104009; PMCID: PMC13424836

Rechercher une publication :

Multimodal investigation of the association between bevacizumab and pulmonary arterial hypertension (nouvel onglet)

Haemodynamic responses to sotatercept and parenteral prostacyclins in pulmonary arterial hypertension patients (nouvel onglet)

Impact of Pulmonary Arterial Hypertension Therapies on Gas Exchange in Portopulmonary Hypertension (nouvel onglet)

Pulmonary vascular reactivity in severe pulmonary hypertension associated with COPD (nouvel onglet)

Effective arterial elastance relates more closely to pulsatile than resistive indices during routine haemodynamic assessment of inoperable chronic thromboembolic pulmonary hypertension (nouvel onglet)

Beyond Heritable PAH: Pulmonary Hypertension in Genetic Syndromes (nouvel onglet)

European Respiratory Society clinical practice guidelines update for the treatment of pulmonary arterial hypertension (nouvel onglet)

Ralinepag for the treatment of pulmonary arterial hypertension (ADVANCE OUTCOMES): a randomised, double-blind, placebo-controlled phase 3 study (nouvel onglet)

Prognostic factors in interstitial lung disease-associated pulmonary hypertension: data from the HYPID cohort and the French Pulmonary Hypertension Registry (nouvel onglet)

Circulating biomarker results from a phase 2 study of seralutinib in pulmonary arterial hypertension (nouvel onglet)